company Gilead Sciences Inc. on Thursday announced it had
received a subpoena from the U.S. Department of Justice
related to its marketing and medical education
programs for three of its anti-HIV medications.
Gilead issued a
statement saying the subpoena requested documents for its
medications Truvada, Viread, and Emtriva. Company officials
said they intended to comply with the subpoena, which
came from the U.S. Attorney's office in San Francisco,
and cooperate in any related government investigation.
Be sure to follow Advocate on your favorite social platform
DON'T MISS THE OUT100 SPECIAL 3 DAY MARATHON STARTING NOVEMBER 24TH!
Journey through the year’s influential Out100 – the most iconic and long-standing celebration of LGBTQ+ icons and allies – in a 1-hour television special spotlighting the LGBTQ+ people shaping the world today.